163 related articles for article (PubMed ID: 38188290)
1. 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
Galvan GC; Friedrich NA; Das S; Daniels JP; Pollan S; Dambal S; Suzuki R; Sanders SE; You S; Tanaka H; Lee YJ; Yuan W; de Bono JS; Vasilevskaya I; Knudsen KE; Freeman MR; Freedland SJ
Front Oncol; 2023; 13():1251297. PubMed ID: 38188290
[TBL] [Abstract][Full Text] [Related]
2. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
[TBL] [Abstract][Full Text] [Related]
3. CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.
Alfaqih MA; Nelson ER; Liu W; Safi R; Jasper JS; Macias E; Geradts J; Thompson JW; Dubois LG; Freeman MR; Chang CY; Chi JT; McDonnell DP; Freedland SJ
Cancer Res; 2017 Apr; 77(7):1662-1673. PubMed ID: 28130224
[TBL] [Abstract][Full Text] [Related]
4. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol.
Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M
Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703
[TBL] [Abstract][Full Text] [Related]
6. CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis.
Liang Z; Chen Y; Wang L; Li D; Yang X; Ma G; Wang Y; Li Y; Zhao H; Liang Y; Niu H
Cell Cycle; 2019 Jan; 18(1):34-45. PubMed ID: 30563407
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.
Paschalis A; Sheehan B; Riisnaes R; Rodrigues DN; Gurel B; Bertan C; Ferreira A; Lambros MBK; Seed G; Yuan W; Dolling D; Welti JC; Neeb A; Sumanasuriya S; Rescigno P; Bianchini D; Tunariu N; Carreira S; Sharp A; Oyen W; de Bono JS
Eur Urol; 2019 Oct; 76(4):469-478. PubMed ID: 31345636
[TBL] [Abstract][Full Text] [Related]
8. CD38 in Advanced Prostate Cancers.
Guo C; Crespo M; Gurel B; Dolling D; Rekowski J; Sharp A; Petremolo A; Sumanasuriya S; Rodrigues DN; Ferreira A; Pereira R; Figueiredo I; Mehra N; Lambros MBK; Neeb A; Gil V; Seed G; Terstappen L; Alimonti A; Drake CG; Yuan W; de Bono JS;
Eur Urol; 2021 Jun; 79(6):736-746. PubMed ID: 33678520
[TBL] [Abstract][Full Text] [Related]
9. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
11. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.
Bieghs V; Hendrikx T; van Gorp PJ; Verheyen F; Guichot YD; Walenbergh SM; Jeurissen ML; Gijbels M; Rensen SS; Bast A; Plat J; Kalhan SC; Koek GH; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
Gastroenterology; 2013 Jan; 144(1):167-178.e1. PubMed ID: 23041327
[TBL] [Abstract][Full Text] [Related]
12. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines.
Woo SY; Lee H; Park SM; Choi HS; Kim J; Kwon M; Sohn J; Nam JH; Kim HS; Song P; Baryawno N; Kim YH; Kim K; Lee D
Cell Death Dis; 2022 Oct; 13(10):916. PubMed ID: 36316327
[TBL] [Abstract][Full Text] [Related]
13. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
Li L; Karanika S; Yang G; Wang J; Park S; Broom BM; Manyam GC; Wu W; Luo Y; Basourakos S; Song JH; Gallick GE; Karantanos T; Korentzelos D; Azad AK; Kim J; Corn PG; Aparicio AM; Logothetis CJ; Troncoso P; Heffernan T; Toniatti C; Lee HS; Lee JS; Zuo X; Chang W; Yin J; Thompson TC
Sci Signal; 2017 May; 10(480):. PubMed ID: 28536297
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice.
Hendrikx T; Jeurissen ML; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Houben T; Guichot YD; Gijbels MJ; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
J Hepatol; 2015 Feb; 62(2):430-6. PubMed ID: 25281859
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
[TBL] [Abstract][Full Text] [Related]
18. Olaparib for the treatment of metastatic prostate cancer.
Dror CM; Wyatt AW; Chi KN
Future Oncol; 2021 Jul; 17(19):2413-2429. PubMed ID: 33769071
[TBL] [Abstract][Full Text] [Related]
19. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
[TBL] [Abstract][Full Text] [Related]
20. RAD51-Mediated DNA Homologous Recombination Is Independent of
Sinha A; Saleh A; Endersby R; Yuan SH; Chokshi CR; Brown KR; Kuzio B; Kauppinen T; Singh SK; Baker SJ; McKinnon PJ; Katyal S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
